Top of this page
Skip navigation, go straight to the content
Research & Development
UCB's goal is to command a leading position in discovering and developing new therapies to treat patients suffering from severe diseases. With one of the strongest pipelines in the sector, our focus is on central nervous system and immunology disorders to provide new treatments for specialists and their patients.
Our key features
- Patients are at the heart of all we do, driving our commitment to the treatment of severe diseases.
- A focus on two key therapeutic areas: Central Nervous System and Immunology disorders.
- A development pipeline of twelve new compounds - NCEs and NBEs - targeting fourteen separate indications.
- An international R&D organisation with over 2,000 staff.
- A track record of successful partnerships with both academia and leading drug discovery organisations. Partnership is part of our philosophy.
